Logo
x

Search

Subscribe Now

Aybintio

Samsung Bioepis to Present P-III Exploratory Analyses Results of Aybintio (bevacizumab- biosimilar) at ESMO 2020

Samsung Bioepis to Present P-III Exploratory Analyses Results of Aybintio (bevacizumab- biosimilar) at ESMO 2020

  • September 17, 2020
Samsung Bioepis' Aybintio (SB8- biosimilar- bevacizumab) Receives the EC's Approval for Launch in EU

Samsung Bioepis' Aybintio (SB8- biosimilar- bevacizumab) Receives the EC's Approval for Launch in EU

  • August 21, 2020
Image

Incisive News in 3 Shots.

Contact Us

Our Information

Follow Us

Copyright © 2024 PharmaShots - All Rights Reserved.